- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01194076
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD) (5dayOCD)
May 29, 2012 updated by: Stephen Whiteside, Mayo Clinic
Wait-list Feasibility Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric OCD
The purpose of this study is to examine how well intensive cognitive-behavioral therapy (CBT) delivered over 5 days works in reducing Obsessive-Compulsive Disorder (OCD) symptoms in children and adolescents.
Treatment will consist of exposure and response prevention with an added focus on teaching parents to be exposure coaches.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Although cognitive-behavioral therapy (CBT) is the most effective intervention for pediatric obsessive-compulsive disorder (OCD), many people do not receive CBT initially due, in part, to the lack of trained providers and geographic barriers (e.g., distance to such providers).
Rather, the majority of youth with OCD receive psychiatric medication alone or together with unproven forms of psychotherapy.
While some serotonergic medications have demonstrated utility in pediatric OCD, side effects can be common, response rates are modest at best, and symptom remission is rare.
Storch et al. have shown that CBT can be delivered effectively in an intensive format over a 3-week time-span; however, even this shortened treatment approach involves considerable time and financial expenditure for those who do not have local access to CBT, including three week's time off from work and the cost of local room and board.
Given this, more efficient ways of providing CBT need to be identified and tested to increase the number of people with access to this form of treatment.
With this in mind, the proposed feasibility study examines the use of videophone technology to evaluate a 5-day cognitive-behavioral intervention for youth with OCD administered at multiple sites.
A total of 30 youth will receive 10 60-75-minute sessions of CBT over 5 days (two sessions a day).
Cognitive-behavioral therapy will be based on a demonstrated effective treatment protocol, and adapted for administration over a one-week time-span.
We will utilize a month-long waitlist control to estimate treatment efficacy.
Comprehensive assessments will be conducted by trained clinicians at relevant time-points (i.e., baseline, post-waitlist, post-treatment, follow-up) to assess symptom severity and impairment.
Should supporting data be found, CBT delivered in a 5-day format would have the potential to help many more families who would otherwise remain untreated or inadequately treated.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33620
- University of South Florida
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
New York
-
Bronx, New York, United States, 10458
- Fordham University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
All patients must meet the following inclusion criteria to be eligible for study participation:
- Principal diagnosis of OCD on the ADIS-IV-P and CY-BOCS Total Score ≥ 16
- No change in psychotropic medication (if applicable) for at least 8 weeks prior to study entry
- 7 to 17 years old
- Availability of at least one parent to accompany the child to all assessment sessions and be present for videophone assessments
- Have a computer and high-speed internet within their home
- English speaking.
Exclusion Criteria:
Patients will be excluded from the study if they meet any of the following criteria:
- History of and/or current psychosis, autism, bipolar disorder, or current suicidality, oppositional defiant disorder, or eating disorder measured by the ADIS-IV-P and all available clinical information
- Principal diagnosis other than OCD
- Current a positive diagnosis in the caregiver of mental retardation, psychosis, or other psychiatric disorders or conditions that would limit their ability to understand CBT (based on clinical interview).
- Participants can be included if they are taking a selective serotonin reuptake inhibitor, SNRI, tricyclic, or antipsychotic provided that no medication changes were made 8 weeks prior to initiation of CBT or during treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 5day intensive treatment
|
Exposure Based Cognitive Behavioral Therapy administered in 10 appointments over 5 days with an added focus on training parents to be exposure coaches
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Children's Yale Brown Obsessive Compulsive Scale (CYBOCS)
Time Frame: 1 month before tx, pre-tx, post-tx, 3 month follow-up
|
The CYBOCS is the gold standard measure of OCD symptoms.
The primary outcome is the decrease in CYBOCS scores from pre-tx to post-tx, and post-tx to follow-up, compared to the change from 1 month before tx to pre-tx.
|
1 month before tx, pre-tx, post-tx, 3 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Spence children's anxiety scale
Time Frame: baseline, pre-tx, post-tx, 3 month follow-up
|
baseline, pre-tx, post-tx, 3 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephen P Whiteside, PhD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (ACTUAL)
May 1, 2012
Study Completion (ACTUAL)
May 1, 2012
Study Registration Dates
First Submitted
August 31, 2010
First Submitted That Met QC Criteria
September 1, 2010
First Posted (ESTIMATE)
September 2, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
May 30, 2012
Last Update Submitted That Met QC Criteria
May 29, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-0082590
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obsessive Compulsive Disorder
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Baylor College of MedicineRecruitingObsessive-Compulsive Disorder | Cognitive Behavioral Therapy | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceUnited States
-
Chaim HuijserLevvelRecruitingObsessive-Compulsive Disorder | Anxiety Disorders and Symptoms | Obsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceNetherlands
-
Stanford UniversityCompletedObsessive Compulsive DisorderUnited States
-
NYU Langone HealthCompletedObsessive Compulsive DisorderUnited States
-
Massachusetts General HospitalActive, not recruitingObsessive Compulsive DisorderUnited States
-
Boston University Charles River CampusCompletedObsessive Compulsive DisorderUnited States
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedObsessive Compulsive DisorderUnited States
-
Karolinska InstitutetCompletedObsessive Compulsive DisorderSweden
-
Roseli ShavittCompleted
Clinical Trials on 5-day intensive treatment
-
Austin Speech LabsUnknownAphasia | LanguageUnited States
-
The University of Hong KongNot yet recruitingStroke | Small Vessel Cerebrovascular Disease
-
BayerCompleted
-
VA Office of Research and DevelopmentCompletedStress Disorders, Post-TraumaticUnited States
-
Saint-Joseph UniversityTerminated
-
Gruppo Italiano per la Valutazione degli Interventi...Not yet recruitingCentral Nervous System Diseases | Cardiac Arrest | Post-Anoxic Coma
-
Gruppo Italiano per la Valutazione degli Interventi...Medical University of Warsaw; European Commission; Semmelweis University; Ben-Gurion... and other collaboratorsCompletedBrain Injuries, TraumaticItaly
-
University College, LondonCompletedPeriodontitis | Intimal Medial Thickness of Internal Carotid ArteryUnited Kingdom
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease and Pisa SyndromeItaly
-
University Hospital of CologneAlbert Einstein College of Medicine; Monash University; The Alfred; Johann Wolfgang... and other collaboratorsNot yet recruiting